tryptophan and Carcinoma, Lewis Lung
tryptophan has been researched along with Carcinoma, Lewis Lung in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Athar, M; Deshane, JS; Hough, KP; Jackson, J; McCusker, RH; Ponnazhagan, S; Strenkowski, JG; Thannickal, VJ; Tousif, S; Wang, Y | 1 |
| Fujigaki, H; Hoshi, M; Kunisawa, K; Mouri, A; Nabeshima, T; Nakamoto, K; Saito, K; Yamamoto, Y; Yamasuge, W | 1 |
| Cheng, J; Li, Z; Liu, M; Ma, B; Min, W; Wang, H; Wang, L; Yao, W; Zeng, X; Zhang, R | 1 |
| Chen, X; Fang, C; Guo, H; Liu, H; Liu, Y; Min, W; Tan, M; Xu, P; Zhang, Y | 1 |
| Calleja, P; Espuelas, S; Irache, JM; Martínez-Oharriz, C; Zandueta, C | 1 |
| Ando, M; Nishikawa, M; Saito, K; Takahashi, Y; Takakura, Y; Watanabe, Y; Watcharanurak, K; Yamamoto, Y; Yoshinaga, K; Zang, L | 1 |
| Le, V; Lin, S; Liu, J; Que, Z; Tian, J; Zhang, A; Zhang, L; Zheng, Y | 1 |
| Cai, S; Du, J; He, Y; Liu, P; Ou, X; Wu, X; Zeng, J | 1 |
Other Studies
8 other study(ies) available for tryptophan and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Indoleamine 2, 3-Dioxygenase Promotes Aryl Hydrocarbon Receptor-Dependent Differentiation Of Regulatory B Cells in Lung Cancer.
Topics: Animals; B-Lymphocytes, Regulatory; Carcinoma, Lewis Lung; Cell Differentiation; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Myeloid-Derived Suppressor Cells; Receptors, Aryl Hydrocarbon; Tryptophan; Tumor Microenvironment | 2021 |
Indoleamine 2,3-dioxygenase 2 depletion suppresses tumor growth in a mouse model of Lewis lung carcinoma.
Topics: Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Gene Knockout Techniques; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-gamma; Kynurenine; Male; Mice; Tryptophan; Tumor Burden; Tumor Escape; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2019 |
IDO inhibitor synergized with radiotherapy to delay tumor growth by reversing T cell exhaustion.
Topics: Animals; B7-H1 Antigen; Carcinoma, Lewis Lung; Combined Modality Therapy; Dendritic Cells; Drug Resistance, Neoplasm; Flow Cytometry; Galectins; Gene Expression Regulation, Neoplastic; Hepatitis A Virus Cellular Receptor 2; Indoleamine-Pyrrole 2,3,-Dioxygenase; Ligands; Programmed Cell Death 1 Receptor; Receptors, Immunologic; T-Lymphocytes, Regulatory; Tryptophan | 2020 |
Silencing IDO2 in dendritic cells: A novel strategy to strengthen cancer immunotherapy in a murine lung cancer model.
Topics: Animals; Cancer Vaccines; Carcinoma, Lewis Lung; Cell Line, Tumor; Coculture Techniques; Dendritic Cells; Female; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; RNA Interference; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Tryptophan; Tumor Necrosis Factor-alpha | 2020 |
A combination of nanosystems for the delivery of cancer chemoimmunotherapeutic combinations: 1-Methyltryptophan nanocrystals and paclitaxel nanoparticles.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line; Female; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Mice, Inbred C57BL; Nanoparticles; Paclitaxel; Particle Size; Solubility; Tryptophan; X-Ray Diffraction | 2017 |
Effects of upregulated indoleamine 2, 3-dioxygenase 1 by interferon γ gene transfer on interferon γ-mediated antitumor activity.
Topics: Animals; Carcinoma, Lewis Lung; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Genetic Therapy; Genetic Vectors; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-gamma; Kidney; Kynurenine; Liver; Lung; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Plasmids; Spleen; Tryptophan; Tumor Cells, Cultured | 2014 |
Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Coculture Techniques; Disease Progression; Drug Screening Assays, Antitumor; Female; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice, Inbred C57BL; Neoplasm Transplantation; Paclitaxel; Saponins; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Triterpenes; Tryptophan; Tumor Burden; Tumor Escape | 2014 |
Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT.
Topics: Animals; Blotting, Western; Cancer Vaccines; Carcinoma, Lewis Lung; Dendritic Cells; Enzyme Inhibitors; Fluorescent Antibody Technique; Immune Tolerance; Immunohistochemistry; Indoleamine-Pyrrole 2,3,-Dioxygenase; Leukocytes, Mononuclear; Lymph Nodes; Male; Mice; Mice, Inbred C57BL; T-Lymphocytes, Cytotoxic; Tryptophan | 2008 |